WO2025180383 - ANTI-TPBG/MUC1 ANTIBODIES AND USES THEREOF

National phase entry is expected:
Publication Number WO/2025/180383
Publication Date 04.09.2025
International Application No. PCT/CN2025/079190
International Filing Date 26.02.2025
Title **
[English] ANTI-TPBG/MUC1 ANTIBODIES AND USES THEREOF
[French] ANTICORPS ANTI-TPBG/MUC1 ET UTILISATIONS ASSOCIÉES
Applicants **
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Inventors
XU, Yangyang
ZHANG, Yifu
SHANG, Chengzhang
YANG, Yi
SHEN, Yuelei
Priority Data
PCT/CN2024/078555   26.02.2024   CN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2911
EPO Filing, Examination, Granting27502
Japan Filing, Examination, Granting3019
South Korea Filing, Examination, Granting3998
USA Filing, Examination, Granting14140
MasterCard Visa
Total: 51,570
Contact Us
Abstract[English] Anti-TPBG/MUC1 antibodies and antibody drug conjugates derived therefrom, and the use thereof are provided.[French] L'invention concerne des anticorps anti-TPBG/MUC1 et des conjugués anticorps-médicament dérivés de ceux-ci, ainsi que des utilisations associées.